KLH conjugated synthetic peptide derived from human IL-12
Purified by Protein A.
0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated Killer cells, and stimulate the production of IFN-gamma by resting PBMC.
PRODUCT SPECIFIC PUBLICATIONS
- Li, Kang, et al. "CD14 overexpression upregulates TNF-??-mediated inflammatory responses and suppresses the malignancy of gastric carcinoma cells."Molecular and cellular biochemistry 376.1-2 (2013): 137-143.3Read more>>
- Friedemann, Markus, et al. "Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks." Advanced Healthcare Materials (2017).Read more>>
- Foulon M et al. Mycolactone toxin induces an inflammatory response by targeting the IL-1beta pathway: Mechanistic insight into Buruli ulcer pathophysiologyPLoS Pathog.2020 Dec 18;16(12):e1009107.Read more>>
paraformaldehyde-fixed, paraffin embedded human colon carcinoma tissue; Antigen retrieval by boiling in sodium citrate buffer(pH6) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 30 minutes; Blocking buffer (normal goat serum) at 37°C for 20min; Antibody incubation with Rabbit Anti-IL12 Polyclonal Antibody, Unconjugated (bs-1789R) at 1:500 overnight at 4°C, followed by a conjugated secondary and DAPI staining
U251 lysates probed with IL12 Polyclonal Antibody, Unconjugated (bs-1789R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.